Cross Loops Laminofab Private Limited Company Logo

Cross Loops Laminofab Private Limited - Company Profile

It is a home & lifestyle private limited company based in Tri Nagar, Delhi, India, established in 2014.

2014 | Tri Nagar, Delhi, India | Active
Last Updated:

About Cross Loops Laminofab Private Limited

Cross Loops Laminofab Private Limited, a active private limited company, was established on 27 February 2014 in Tri Nagar, Delhi, India. Engaging in textile retail & distribution within the manufacturing sector, it holds CIN: U17110DL2014PTC265502. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Nikhil Tayal (Director), Ayush Bansal (Director). Past directors included Madhu Tayal. It holds ₹3.21 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No 2/1 Onkar Nagar-B, Tri Nagar, Delhi, 110035.

Company Details

  • CIN/LLPIN

    U17110DL2014PTC265502

  • Registration Number

    265502

  • Incorporation Date

    27 February 2014

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 11 Year, 10 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 3.21 Cr
  • Revenue Growth 17.29%
  • Profit Growth 42.91%
  • Ebitda -6.72%
  • Net Worth 25.58%
  • Total Assets 26.29%
Company report

Cross Loops Laminofab Private Limited

Company Report FY 2025-2026

Explore comprehensive insights into Cross Loops Laminofab Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element

Who are the key members and board of directors at Cross Loops Laminofab Private Limited?

Current Directors

NameDesignationAppointment DateStatus
Nikhil TayalDirector27 Feb 2014Current
Ayush BansalDirector27 Feb 2014Current

Past Directors

NameDesignationCessationStatus
Pramod AbcsddDirector18 Jul 2022Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Cross Loops Laminofab.

Cross Loops Laminofab Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.29% increase. The company also saw a substantial improvement in profitability, with a 42.91% increase in profit. The company's net worth Soared by an impressive increase of 25.58%.

Cross Loops Laminofab revenue growth over time
Cross Loops Laminofab profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
17.29%
Revenue from Operations
17.30%
Total Assets
26.29%
Profit or Loss
42.91%
Net Worth
25.58%
EBITDA
-6.72%

What is the Ownership and Shareholding Structure of Cross Loops Laminofab?

In 2020, Cross Loops Laminofab had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹32,148,940.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Hdfc Bank Limited : 1.61 Cr
  • Yes Bank Limited : 1.60 Cr

Latest Charge Details

DateLenderAmountStatus
13 May 2024Yes Bank Limited₹1.60 CrOpen
27 Aug 2018Hdfc Bank Limited₹1.61 CrOpen

Explore comprehensive loan charge details -

How Many Employees Work at Cross Loops Laminofab?

Unlock and access historical data on people associated with Cross Loops Laminofab, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Cross Loops Laminofab Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Cross Loops Laminofab, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cross Loops Laminofab's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Cross Loops Laminofab

Recent Activity within the Organization

  • Charges

    Progress on A charge with Yes Bank Limited of Rs. 16.00 M registered on 13 May 2024 with Charge ID 100923334 was modified on 21 Nov 2024. was documented.

  • Annual General Meeting

    Progress on Cross Loops Laminofab Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Yes Bank Limited amounted to Rs. 16.00 M with Charge ID 100923334 was registered on 13 May 2024. was documented.

  • Balance Sheet

    Cross Loops Laminofab Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 16.15 M registered on 27 Aug 2018 with Charge ID 100200127 was modified on 27 May 2022. was documented.

  • Charges

    A charge with Hdfc Bank Limited amounted to Rs. 16.15 M with Charge ID 100200127 was registered on 27 Aug 2018. was recorded as a recent event.

Frequently Asked Questions

  • What is the CIN of Cross Loops Laminofab Private Limited?

    The CIN of Cross Loops Laminofab Private Limited is U17110DL2014PTC265502.

  • Where is Cross Loops Laminofab Private Limited headquartered?

    Cross Loops Laminofab Private Limited is headquartered at House No 2/1 Onkar Nagar-B, Tri Nagar, Delhi, 110035.

  • When was Cross Loops Laminofab Private Limited incorporated?

    Cross Loops Laminofab Private Limited was incorporated on 27 February 2014.

  • Who are the current directors of Cross Loops Laminofab Private Limited?

    The current directors of Cross Loops Laminofab Private Limited are

  • What is the primary industry of Cross Loops Laminofab Private Limited?

    The primary industry of Cross Loops Laminofab Private Limited is Manufacturing.

  • Is Cross Loops Laminofab Private Limited a listed company?

    Cross Loops Laminofab Private Limited is unlisted.

  • What is the capital structure of Cross Loops Laminofab Private Limited?

    The authorized capital of Cross Loops Laminofab Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

  • What is the compliance status of Cross Loops Laminofab Private Limited?

    The compliance status of Cross Loops Laminofab Private Limited is Compliant.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial